Skip to content
Recall Observatory FDA recall evidence

Drug product

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

D-66373-001

September 25, 2013

Class III

Product summary

Firm
Sandoz Incorporated
Event
Event 66373
Status
Terminated
Classification
Class III
Quantity
25,830 bottles
Official record key
drug-enforcement:D-66373-001

Official wording

Reason: Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

Code information: Lot #: BU3417, Exp 06/2014

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

Field note

Send feedback

We'll only use this to respond to your feedback.